Denali Therapeutics Inc. (DNLI)
20.83
2.09 (11.15%)
At close: Jan 15, 2025, 12:55 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 127.11M | 218.04M | 293.48M | 507.14M | 79.45M | 77.12M | 218.38M | 39.85M | 30.74M |
| Short-Term Investments | 907.40M | 1.12B | 571.93M | 962.55M | 335.91M | 387.17M | 187.85M | 138.48M | n/a |
| Long-Term Investments | n/a | 1.50M | 425.45M | 32.70M | 39.89M | 147.88M | 60.75M | 73.08M | 84.00K |
| Other Long-Term Assets | 18.14M | 11.90M | 11.87M | 2.46M | 2.66M | 8.11M | 1.44M | 770.00K | n/a |
| Receivables | 3.42M | 9.28M | 1.23M | n/a | n/a | 8.55M | 464.00K | 438.00K | n/a |
| Inventory | n/a | -5.00M | n/a | n/a | n/a | -8.55M | -464.00K | n/a | n/a |
| Other Current Assets | 26.21M | 26.82M | 30.60M | 20.28M | 29.35M | 7.99M | 1.87M | 556.00K | 66.00K |
| Total Current Assets | 1.06B | 1.37B | 897.23M | 1.50B | 430.03M | 480.84M | 409.61M | 181.96M | 33.43M |
| Property-Plant & Equipment | 71.64M | 74.52M | 69.61M | 73.46M | 80.66M | 25.16M | 14.92M | 15.26M | 3.17M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 89.78M | 87.92M | 506.93M | 108.63M | 123.20M | 181.15M | 77.11M | 89.11M | 3.25M |
| Total Assets | 1.15B | 1.46B | 1.40B | 1.60B | 553.23M | 661.98M | 486.72M | 271.07M | 36.68M |
| Account Payables | 9.48M | 2.79M | 4.78M | 1.07M | 2.59M | 1.89M | 2.72M | 1.96M | 1.71M |
| Deferred Revenue | n/a | 290.05M | 320.30M | 23.48M | 18.74M | 11.43M | n/a | n/a | n/a |
| Short-Term Debt | 7.26M | 7.32M | 5.45M | 4.69M | 3.67M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 61.24M | 63.76M | 47.71M | 42.45M | 20.35M | 19.47M | 11.45M | 7.14M | 1.77M |
| Total Current Liabilities | 77.98M | 363.92M | 378.25M | 71.70M | 45.34M | 32.79M | 14.16M | 9.11M | 3.48M |
| Long-Term Debt | 44.98M | 53.03M | 58.55M | 64.17M | 68.86M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | 379.00K | 379.00K | 701.00K | 379.00K | 25.00M | 6.76M | 7.44M | 48.84M |
| Total Long-Term Liabilities | 44.98M | 53.89M | 63.63M | 382.05M | 113.00M | 82.35M | 6.76M | 7.44M | 48.84M |
| Total Liabilities | 122.96M | 417.81M | 441.87M | 453.75M | 158.34M | 115.14M | 20.93M | 16.55M | 52.32M |
| Total Debt | 52.24M | 60.35M | 58.55M | 64.17M | 68.86M | n/a | n/a | n/a | n/a |
| Common Stock | 1.71M | 1.69M | 1.55M | 1.53M | 1.29M | 1.27M | 1.20M | 2.69M | 170.00K |
| Retained Earnings | -1.12B | -970.99M | -645.00M | -354.42M | -425.55M | -227.94M | -191.70M | -103.51M | -16.86M |
| Comprehensive Income | 643.00K | -6.89M | -2.50M | -245.00K | 350.00K | -649.00K | -368.00K | -373.00K | -48.31M |
| Shareholders Equity | 1.03B | 1.04B | 962.29M | 1.15B | 394.89M | 546.85M | 465.80M | 254.52M | -15.63M |
| Total Investments | 907.40M | 1.12B | 997.38M | 995.25M | 375.79M | 535.05M | 249.10M | 211.56M | 84.00K |